Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.64%107.31M | -20.81%542.25M | 15.35%201.17M | -40.53%99.93M | -41.67%123.85M | -9.61%117.47M | -17.69%684.73M | -36.77%174.4M | -39.18%168.04M | 40.52%212.33M |
| Cost of revenue | -22.25%430.96M | -18.74%554.32M | ||||||||
| Gross profit | -14.66%111.29M | -12.92%130.41M | ||||||||
| Operating expense | -12.11%92.75M | -2.32%69.75M | 23.77%174.07M | -39.70%90.41M | -43.31%108.59M | -10.23%105.53M | -63.37%71.4M | 147.75%140.63M | -41.34%149.92M | 48.35%191.54M |
| Selling and administrative expenses | ---- | -2.32%69.75M | ---- | ---- | ---- | ---- | -63.37%71.4M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 17.43%8.5M | ---- | ---- | ---- | ---- | 9.91%7.24M | ---- | ---- | ---- |
| -General and administrative expense | ---- | -4.55%61.25M | ---- | ---- | ---- | ---- | -65.93%64.17M | ---- | ---- | ---- |
| Other operating expenses | -5.48%101.79M | -20.04%512.28M | 14.34%200.29M | -38.64%93.36M | -42.85%110.94M | -9.72%107.69M | --640.71M | --175.17M | -41.00%152.15M | 47.79%194.11M |
| Total other operating income | 319.73%9.04M | -17.95%33.68M | -24.07%26.22M | 32.93%2.96M | -8.44%2.35M | 24.80%2.15M | --41.05M | --34.54M | -2.03%2.22M | 15.19%2.57M |
| Operating profit | 22.06%14.57M | -29.60%41.54M | -19.72%27.11M | -47.45%9.52M | -26.61%15.26M | -3.79%11.93M | 230.65%59.01M | 130.20%33.77M | -12.54%18.12M | -5.48%20.79M |
| Net non-operating interest income (expenses) | 15.58%-6.3M | 13.41%-36.18M | 9.94%-10.14M | 6.66%-9.21M | 15.67%-9.15M | 23.99%-7.46M | 35.58%-41.78M | 65.69%-11.25M | 21.67%-9.87M | -7.06%-10.85M |
| Non-operating interest expense | -15.58%6.3M | -13.41%36.18M | -9.94%10.14M | -6.66%9.21M | -15.67%9.15M | -23.99%7.46M | 15.97%41.78M | 183.24%11.25M | -21.67%9.87M | 7.06%10.85M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -103.19%-13K | 383.26%2.31M | 726.77%1.05M | -58.04%235K | 834.52%617K | 426.40%408K | 101.41%478K | 102.94%127K | 150.68%560K | 99.35%-84K |
| Special income (charges) | 19.16%-12.11M | -242.95%-14.98M | ||||||||
| Less:Write off | ---- | -19.16%12.11M | ---- | ---- | ---- | ---- | 242.95%14.98M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -15.32%34.77M | -42.22%41.05M | ||||||||
| Income before tax | 69.17%8.25M | -30.73%30.32M | -20.40%18.02M | -93.77%549K | -31.76%6.73M | 98.37%4.88M | 156.72%43.77M | 127.52%22.64M | 25.61%8.82M | 1,089.76%9.86M |
| Income tax | -88.38%303K | 29.61%23.18M | 196.94%16.47M | -112.77%-478K | -41.40%4.58M | 238.13%2.61M | -17.41%17.89M | 1,895.68%5.55M | -40.28%3.74M | 22.72%7.82M |
| Net income | 250.02%7.95M | -72.42%7.14M | -90.94%1.55M | -79.75%1.03M | 5.26%2.14M | 34.54%2.27M | 126.20%25.89M | 120.71%17.09M | 577.04%5.07M | 127.63%2.04M |
| Net income continuous operations | 250.02%7.95M | -72.42%7.14M | -90.94%1.55M | -79.75%1.03M | 5.26%2.14M | 34.54%2.27M | 126.20%25.89M | 120.71%17.09M | 577.04%5.07M | 127.63%2.04M |
| Noncontrolling interests | -4.64%-699K | 30.49%-2.71M | 82.16%-691K | -9,614.29%-680K | -7,388.89%-674K | -5,038.46%-668K | 74.89%-3.9M | 75.05%-3.87M | -133.33%-7K | -80.00%-9K |
| Net income attributable to the company | 194.25%8.65M | -66.92%9.85M | -89.32%2.24M | -66.38%1.71M | 37.75%2.82M | 72.78%2.94M | 135.77%29.79M | 131.29%20.97M | 575.27%5.08M | 127.77%2.05M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 194.25%8.65M | -66.92%9.85M | -89.32%2.24M | -66.38%1.71M | 37.75%2.82M | 72.78%2.94M | 135.77%29.79M | 131.29%20.97M | 575.27%5.08M | 127.77%2.05M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 169.64%0.0151 | -68.09%0.018 | -90.18%0.0039 | -68.75%0.003 | 35.90%0.0053 | 75.00%0.0056 | 135.76%0.0564 | 131.28%0.0397 | 585.71%0.0096 | 128.06%0.0039 |
| Diluted earnings per share | 169.64%0.0151 | -68.09%0.018 | -90.18%0.0039 | -68.75%0.003 | 35.90%0.0053 | 75.00%0.0056 | 135.76%0.0564 | 131.28%0.0397 | 585.71%0.0096 | 128.06%0.0039 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.